Caroline Pot

Lausanne, VD, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 104 publications

Serum Glial Fibrillary Acidic Protein Dynamics, Disease Progression, and Therapy Response in Multiple Sclerosis.

Serum Glial Fibrillary Acidic Protein Dynamics, Disease Progression, and Therapy Response in Multiple Sclerosis.

Journal: JAMA neurology

Published: August 03, 2026

Anti-CD20 B cell depletion is associated with elevated mucosal-originating circulating regulatory IgA B cells in multiple sclerosis.

Anti-CD20 B cell depletion is associated with elevated mucosal-originating circulating regulatory IgA B cells in multiple sclerosis.

Journal: Science translational medicine

Published: July 22, 2026

Emerging CSF and Serum Biomarkers in Multiple Sclerosis: Cytokines, MOG, GFAP, and Beyond.

Emerging CSF and Serum Biomarkers in Multiple Sclerosis: Cytokines, MOG, GFAP, and Beyond.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: April 23, 2026

Real-world practices and challenges of radiologically isolated syndrome: results of a cross-sector survey by the DACH MS guidelines group.

Real-world practices and challenges of radiologically isolated syndrome: results of a cross-sector survey by the DACH MS guidelines group.

Journal: Frontiers in neurology

Published: March 04, 2026

Neurology : what's new in 2025

Neurology : what's new in 2025

Journal: Revue medicale suisse

Published: January 22, 2026

Associations of chrononutrition and sleep with fatigue in multiple sclerosis: an analysis of the Swiss Multiple Sclerosis Registry.

Associations of chrononutrition and sleep with fatigue in multiple sclerosis: an analysis of the Swiss Multiple Sclerosis Registry.

Journal: BMJ neurology open

Published: November 28, 2025

Patient SAtisfaction with the TYSabri SC Formulation - A Swiss multi-centriC, prospective non-intervenTIONal study: the SATYSFACTION study.

Patient SAtisfaction with the TYSabri SC Formulation - A Swiss multi-centriC, prospective non-intervenTIONal study: the SATYSFACTION study.

Journal: Therapeutic advances in neurological disorders

Published: November 25, 2025

Sex differences in the development, treatment, and prognosis of multiple sclerosis in Switzerland.

Sex differences in the development, treatment, and prognosis of multiple sclerosis in Switzerland.

Journal: Frontiers in neuroscience

Published: November 13, 2025

Serum GFAP as a biomarker for progression in multiple sclerosis: assay comparison and a large reference database of healthy controls.

Serum GFAP as a biomarker for progression in multiple sclerosis: assay comparison and a large reference database of healthy controls.

Journal: Clinical chemistry and laboratory medicine

Published: November 08, 2025

Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activity.

Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activity.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: November 05, 2025

Metabolic profiles of the human blood-brain barrier cells treated by TNF-alpha and oxysterols.

Metabolic profiles of the human blood-brain barrier cells treated by TNF-alpha and oxysterols.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 06, 2025

Unraveling Microstructural and Macrostructural Brain Age Dynamics in Multiple Sclerosis.

Unraveling Microstructural and Macrostructural Brain Age Dynamics in Multiple Sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: August 19, 2025

Showing 1-12 of 104

Last Updated: 09/26/2026